CSL’s R&D chief says the company’s new hereditary angioedema treatment is one of only a few drugs to be built from scratch in Australia.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
St George Mining is deepening ties with local government and the community in Minas Gerais, Brazil, as it moves to develop the Araxá niobium-REE project.
LinQ Minerals is breaking the drought for gold IPOs on the ASX, raising $10m to explore and develop the 3.7Moz Gilmore project in NSW.
If Island Pharma’s drug keeps delivering in clinical trials, it could fast track approval and make a real difference in the fight against dengue.
